Simultaneous detection of methylphenidate and its main metabolite, ritalinic acid, in doping control.
Two analytical methods for the simultaneous detection in urine of methylphenidate and its main metabolite, ritalinic acid, are described. Both procedures are based on solid-phase extraction of urine samples on Bond Elut Certify columns, and capillary gas chromatographic-mass spectrometric detection of O-trimethylsilyl, N-trifluoroacetyl derivatives. The former method is used as a general screening procedure for the detection of basic polar nitrogen-containing compounds in urine such as stimulants, narcotic and adrenergic drugs. The latter procedure is proposed as a specific method to confirm methylphenidate ingestion. The two methods are sensitive enough to detect methylphenidate and ritalinic acid in urine at least for 24 h after administration of a therapeutic dose (20 mg oral dose) of methylphenidate.
Solans
A
A
Department of Pharmacology and Toxicology, Universitat Autònoma de Barcelona, Spain.
Carnicero
M
M
De La Torre
R
R
Segura
J
J
D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007202:Indicators and Reagents; D008297:Male; D008774:Methylphenidate / Q000031:analogs & derivatives* / Q000032:analysis; D015813:Substance Abuse Detection / Q000379:methods*
D007202:Indicators and Reagents; D008774:Methylphenidate; C009189:ritalinic acid